Skip to the page

Data / Form D filings / Cynaptec Pharmaceuticals, Inc.

Cynaptec Pharmaceuticals, Inc.: Form D filing

Cynaptec Pharmaceuticals, Inc., a biotechnology company in Stuart, FL, filed a Form D with the SEC in 2025. The latest, on April 17, 2025, reports $6 million sold of a $26 million offering to 1 investor.

SpecStream is the live web data engine for teams and agents. It reads every Form D on SEC EDGAR the day it is filed, and this page is that reading. Ask for your own cut (a state, an industry, a size) and new filings arrive in your sheet, CRM, Slack or agent as they land.

Company details from the filing

Address
4244 SE CENTERBOARD LANE, Stuart, FL, 34997
Phone
(561) 891-1737
Industry
Biotechnology
Entity type
Corporation
Incorporated in
Delaware
Year incorporated
2025
Revenue range
Decline to Disclose
Exemptions claimed
Rule 506(b)
SEC identifier (CIK)
2058683

Form D filings

FiledTypeOfferingSoldRemainingInvestorsFirst saleFiling
Apr 17, 2025New notice$26,000,000$6,000,000$20,000,0001Apr 11, 2025sec.gov

Executive officers and directors named in the filing

NameRoleNote in the filing
JONAH F SHACKNAIDirector
CHARLES F GOULBURN IIDirector
WESLEY F RAMJEETDirector
FREDERICK SANCILIOExecutive Officer, Director
SETH F RODNERDirector

Other biotechnology companies in Florida that filed recently

Every Form D from the week of Apr 14, 2025 · All recent filings in Florida · All recent Biotechnology filings

Read from SEC EDGAR. Amount sold is what Cynaptec Pharmaceuticals, Inc. reported on the day it filed; on an offering that is still open, a later amendment can raise it. Free to reuse with credit to SpecStream under CC BY 4.0.